Interpretation of Thrombosis Prevention Trial.
FitzGerald
G A
GA
Charman
W N
WN
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D003328:Coronary Thrombosis / Q000517:prevention & control*; D006801:Humans; D008019:Life Style; D008297:Male; D017202:Myocardial Ischemia / Q000517:prevention & control*; D012307:Risk Factors; D016540:Smoking Cessation; D016896:Treatment Outcome; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects
D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin